
Pharmaceutical ResearchJun 12, 2026
Advancing Drug Discovery Through AI-Driven Research
How artificial intelligence is accelerating early-stage compound discovery and reshaping research timelines.
Articles, analysis, and updates from Idera's scientific, regulatory, and consulting teams.

How artificial intelligence is accelerating early-stage compound discovery and reshaping research timelines.

Digital therapeutics, remote monitoring, and connected devices are redefining the patient experience.

Adaptive protocols, decentralized trials, and patient-centered endpoints are setting new standards.

What harmonized regulations mean for manufacturers and developers entering multi-region markets.

Embedding QbD principles into manufacturing processes for consistent, audit-ready outcomes.

Strategies for productive partnerships between industry, academia, and clinical organizations.